ORACLE INVESTMENT MANAGEMENT INC
Q4 2025 Form 13-F
GREENWICH, CONNECTICUT
CIK 0001012622
· CRD 138127
· Exempt reporting adviser
$167.9M Reported Value Total
ORACLE INVESTMENT MANAGEMENT, INC. reports under management (AUM).
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
5 funds
· $357.6M gross asset value
Hedge Fund: $357.6M
Source: Form ADV filed 2026-03-31
Reported value
$167.9M
Quarter over quarter
+12.9%
Holdings
17
Top-10 concentration
94.3%
Key People
Form ADV owners & control persons
Larry Neil Feinberg
SOLE OWNER OF ORACLE INVESTMENT MANAGEMENT, INC. AND MANAGING MEMBER OF ORACLE ASSOCIATES, LLC (RELYING ADVISER)
Mitchell David Vogel
CHIEF FINANCIAL OFFICER / CHIEF COMPLIANCE OFFICER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q4 2025 13F record
Q4 2025 13F filing summary
| Period of report | December 31, 2025 |
|---|---|
| Filed | February 18, 2026 |
| Form | 13F-HR |
| Reported value | $167.9M |
| Positions | 17 |
| Change in reported value | +4.9% |
| New positions | 6 |
| Exited positions | 5 |
| Position turnover | 50.0% |
| Top-10 concentration | 94.3% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2025 13F
Filed Feb 18, 2026
|
17 | $167.9M |
|
Q3 2025 13F
Filed Nov 19, 2025
|
16 | $160.1M |
|
Q2 2025 13F
Filed Aug 15, 2025
|
9 | $145.8M |
|
Q1 2025 13F
Filed May 15, 2025
|
11 | $198.2M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
13 | $183.7M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
15 | $166.9M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
16 | $107.2M |
|
Q1 2024 13F
Filed May 15, 2024
|
18 | $150.5M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
18 | $164.4M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
19 | $325.8M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
21 | $135.7M |
|
Q1 2023 13F
Filed May 15, 2023
|
19 | $103.3M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
17 | $119.9M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
19 | $176.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
22 | $329.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
23 | $505.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
21 | $703.7M |
|
Q3 2021 13F
Filed Nov 15, 2021
|
28 | $803.2M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
25 | $725.6M |
|
Q1 2021 13F
Filed May 17, 2021
|
22 | $667.8M |
31 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q4 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | WGS GENEDX HOLDINGS CORP | $115.1M | 68.51% |
| 2 | ARDX ARDELYX INC | $10.9M | 6.5% |
| 3 | BHVN BIOHAVEN LTD | $8.7M | 5.19% |
| 4 | TDOC C TELADOC HEALTH INC | $4.6M | 2.71% |
| 5 | NVAX 5 12/15/27 C NOVAVAX INC | $4.0M | 2.4% |
| 6 | ARDX C ARDELYX INC | $3.5M | 2.08% |
| 7 | QDEL QUIDELORTHO CORP | $3.4M | 2.01% |
| 8 | FORA FORIAN INC | $2.9M | 1.72% |
| 9 | PSNL PERSONALIS INC | $2.7M | 1.61% |
| 10 | BHVN C BIOHAVEN LTD | $2.6M | 1.57% |
| 11 | TDOC TELADOC HEALTH INC | $2.5M | 1.48% |
| 12 | TSHA TAYSHA GENE THERAPIES INC | $1.5M | 0.87% |
| 13 | CAVA CAVA GROUP INC | $1.0M | 0.6% |
| 14 | EWTX EDGEWISE THERAPEUTICS INC | $951.5K | 0.57% |
| 15 | DAWN DAY ONE BIOPHARMACEUTICALS I | $932.0K | 0.55% |
| 16 | PFE C PFIZER INC | $622.5K | 0.37% |
| 17 | ARKG ARK ETF TR | $564.9K | 0.34% |
| 18 | SGMOQ SANGAMO THERAPEUTICS INC | $435.0K | 0.26% |
| 19 | BIIB BIOGEN INC | $424.5K | 0.25% |
| 20 | TEM TEMPUS AI INC | $384.2K | 0.23% |
Values as reported on the Q4 2025 Form 13F. Every position is in the holdings table below.